Logo.png
Phoenix Life Sciences International Is Now Accepting Bids for Hemp CBD Producers and Manufacturers
12. Dezember 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it is...
Logo.png
Phoenix Life Sciences International Announces the Release of the Company’s Investor Relations Deck and Accompanying Video Presentation
06. Dezember 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it...
Logo.png
Phoenix Life Sciences International Announces Angus Stewart as Company’s New Agriculture and Horticulture Senior Advisor
28. November 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that Angus...
Logo.png
Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu
14. November 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Logo.png
Phoenix Life Sciences International Announces Significant Retirement of Convertible Debt and Elimination of Outstanding Preferred Shares
13. November 2018 09:00 ET | Phoenix Life Sciences International
DENVER , Nov. 13, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”) (OTC: PLSI), an international adaptive healthcare solutions company, today announced that it...
Logo.png
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
05. November 2018 12:15 ET | Phoenix Life Sciences International
DENVER, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has...
Logo.png
Phoenix Life Sciences International Receives Approval for Name Change, Symbol Change, and Completion of Consolidation of Businesses
02. November 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced it has...
Logo.png
Phoenix Life Sciences International Announces Dr. Philip Blair as Diabetes Director of Medical Advisory Council
25. Oktober 2018 09:45 ET | Phoenix Life Sciences International
DENVER, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Logo.png
Phoenix Life Sciences International Receives Government Approval to Produce Botanical Pharmaceutical Products in South Pacific
10. Oktober 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: MJMD) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced...
Logo.png
Phoenix Life Sciences International Announces New Board of Directors and Executive Team
03. Oktober 2018 09:00 ET | Phoenix Life Sciences International
DENVER, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of...